From the wire: The EU ERA-NET initiative EuroNanoMed will support eight transnational research projects with €17 million based on the result of its first call for proposals, reports the Cordis website. Launched in May 2009, the call sought proposals that promoted collaborative and interdisciplinary research into nanomedicine.
EuroNanoMed’s first call for proposals focused on the use of nanotechnology in medical diagnostics, targeted drug delivery and regenerative medicine. A second call will be launched in 2010. The two calls have a joint budget between €40 million and €60 million; the allocation of funds for project proposals was based on scientific, technical, translational and/or commercial potential criteria.
EuroNanoMed was set up to support research into nanomedicine through EU-wide R&D projects. Its partners hail from 18 countries and include public health institutions, universities and industry. Its aim is to foster competitiveness by pushing forward innovative knowledge in the area through national and transnational research projects in the field of nanomedicine.
“The projects address very significant medical needs with high-quality science and technology and will develop an industrial vision for new and effective patient applications,” says Professor Frank Barry, chair of the international review panel for EuroNanoMed. He emphasised the high quality of the projects selected by EuroNanoMed, as well as their international competitiveness and innovative potential.
EuroNanoMed aims to bridge the gap between industry and academia in nanomedicine. By creating multidisciplinary research projects that bring together players from industry and academia, the initiative will improve continuity between research results and their application in industry for nanomedicine technologies.